The plasma appearance of newly synthesized cholesterol in anhepatic laboratory diet-fed rats was 10% of the intact rat. In intact rats this cholesterol was mainly ester in lower density lipoproteins, but for anhepatic rats it was virtually only free in high density lipoprotein. Chylomicron cholesterol ester was removed much more slowly from anhepatic than control plasma and returned primarily as free in high density lipoproteins, with the control return 10 times the anhepatic return. Lower density lipoprotein cholesterol ester transfer to an extravascular pool in anhepatic rats was < 10% ofcontrols. The liver was responsible for 95% of the extravascular lower density lipoprotein ester pool and only 50% of the for high density lipoprotein ester. Despite decreased anhepatic lipoprotein catabolism, the mass of both plasma low and high density lipoproteins progressively decreased indicating an even greater decrease in influx. The anhepatic fractional catabolic rate of apo Al was similar to controls, but that of apo E was considerably less. Despite the unchanged catabolism of apo Al and the reduced catabolism of apo E, plasma apo Al decreased less than apo E after hepatectomy. The anhepatic data confirm the pivotal role of the liver in maintaining plasma low and high density lipoprotein cholesterol concentrations. They suggest that, in addition to its anabolic and catabolic functions, the liver also acts as a reservoir buffering changes in plasma concentration. (J. Clin. Invest.
Introduction
The liver is recognized as the main organ responsible for plasma lipoprotein cholesterol homeostasis (1, 2) . The presence of low density lipoprotein (LDL) receptors is considered (2) to be central to the control of the plasma concentration of LDL cholesterol. Enteral cholesterol is also processed in the liver after retrieval by the remnant uptake system (3, 4) . This, subsequently, affects plasma cholesterol content primarily by regulating hepatic LDL receptor activity (5) . Substantial information exists on the hepatic regulation of lipoprotein catabolism. However, comparatively fewer data have been developed on regulation ofhepatic lipoprotein secretion or the role ofthe liver in lipoprotein interconversion.
Hepatectomy has been used (6) to obtain chylomicron remnants, but because of the brief postoperative survival, the model has had limited use in lipoprotein studies. 1 h after func-tional hepatectomy, decreases in plasma triglyceride-rich lipoproteins and increments in LDL and HDL cholesterol and apolipoprotein (apo) E were observed (7) . The presence of necrotic viscera in situ with potential plasma contamination makes interpretation of these data difficult. A hepatectomy model (8) that entails removing the liver while preserving the remaining splanchnic viscera results in survivals in days rather than hours. This model permits longer-term evaluations ofanhepatic plasma cholesterol transport. Comparing this anhepatic data with that ofthe intact rat provide insights into the role of the liver in plasma lipoprotein cholesterol transport and are presented here.
Methods
Chemicals and radiochemicals. [ Animal procedures. All rats were male Sprague Dawley obtained from Charles River Breeding Laboratories, Inc. (Raleigh, NC) weighing between 240 and 350 g. The rats were maintained on standard rat laboratory diet and diurnal lighting. They were fasted from 6 to 12 h the night before the removal ofthe liver. The hepatectomy was performed by a method previously described from this laboratory (8) , which involved the insertion of a prosthesis between the portal vein and vena cava in a one-stage procedure removing the entire liver. An intraarterial line was inserted with glucose and albumin infusions provided to avoid hypoglycemia (8) usually at 2 h after surgery, and sequential blood samples were obtained. Both control and anhepatic rats were maintained in restraint during those studies. At the conclusion of the studies, plasma and tissues (skeletal muscle, heart, adipose, lung, spleen) were obtained for radiolabel assay.
Chylomicrons were obtained from the intestinal lymphatics ofstandard laboratory diet-fed rats by the method of Bollman et al. (9) . A mixture of 50 mg of triolein, 25 mg of monolein, and 25 mg of oleic acid containing [5] [6] [7] [8] [9] [10] ,uCi [4-'4C] cholesterol was infused into the duodenal cannula and the intestinal lymph was drained overnight at 4°C. The chylomicrons were incubated with red cell ghosts to minimize their content of radiolabeled free cholesterol, and the depleted chylomicrons were used on the same day of their collection.
Lipoprotein and apoprotein preparation. Chylomicrons were isolated from the intestinal lymph by a 1 X 106 g-min centrifugation at d 1.006 employing a model L5-65 ultracentrifuge (Beckman Instruments, Inc., Palo Alto, CA) and a Ti6O rotor. LDL were obtained from rat serum at d < 1.063 and 1 x I0 g-min after removing chylomicrons previously injected (7 d) with [ 1,2-3H] cholesterol. The isolated lipoproteins were dialyzed against 0.14 M NaCi, 0.02 M P04 (pH 7.4) (PBS) and then incubated with red blood cell ghosts with repeated changes to minimize the 3H in free cholesterol. The HDL were applied to a heparin sepharose (Sigma Chemical Co.) column as described (10) to obtain the unbound (AI-HDL) fraction containing little apo E. The bound HDL were lyophilized and delipidated with 3:1 ethanol/diethyl ether. The apoproteins were then dissolved in PBS and applied to heparin sepharose to isolate apo E and apo Al. Both of these apolipoproteins and bovine serum albumin were iodinated with 1251 using the modified iodine monochloride method (1 1). The iodinated apolipoproteins and albumin were extensively dialyzed against PBS and the apolipoproteins checked for tracer distribution in an SDS polyacrylamide system (12) . If > 3% of tracer was distributed in areas other than the protein mass, the labeled apoprotein was repurified. The iodinated apoproteins were added to 1 ml of rat plasma before arterial injection.
Chemical and radiochemical analysis. Plasma was extracted by the Dole techniques (13) in all studies evaluating plasma radiolabeled cholesterol content. Free cholesterol was separated from cholesterol ester by thin-layer chromatography on silica gel G using heptane-diethyl ether-glacial acetic acid (80:20:1). The bands were identified by brief 12 exposure, removed, and eluted with 1:1 ethanol-diethyl ether and radioassayed in 0.5% diphenyloxazole in toluene. On each thin-layer plate a standard tracer cholesterol-cholesteryl oleate was run to determine recovery. This was always > 87% for each compound. Radioassay was done in a model LS8 100 liquid scintillation spectrophotometer (Beckman Instruments, Inc., Irvine, CA). Plasma 1251I was assayed in the 10% trichloroacetic acid precipitate in a TRICARB model 4530 y counter (Packard Instrument Co., Inc., Donners Grove, IL).
The plasma free cholesterol mass assay was performed either by a colorimetric method (14) or with an enzymatic technique (Wako Chemicals, Richmond, VA). Total cholesterol was assayed either with the procedure of Abell et al. (15) or with an enzymatic system (Wako Chemicals). Protein assays were performed by the Lowry method (16) and phospholipids by the Bartlett (17) colorimetric assay of phosphorous in the digested lipid extract. Along with ultracentrifugation, heparin manganese precipitation (18) was used to isolate the HDL from LDL.
Calculations. Kinetic analysis ofthe LDL and HDL [3H]cholesterol ester used a two-pool model to simulate the two-exponential function. A plasma compartment from which catabolism (or transfer to a slow turnover pool) occurred and an extravascular pool from which no catabolism occurred. The same model was used for the '251-apo E and apo Al studies. The simulation was done with a SAAM 29 (19) program on a UNIX PC. Means ofthe data and standard errors were determined by routine methods (20) . Significance evaluations ofdata used a one-sided t test (20) .
Results
After the arterial injection of either 15 uCi of RS[5-3H]-mevalonolactone or 5 1,Ci of RS[2-14C]mevalonolactone into intact rats, a prompt appearance in plasma radiolabeled cholesterol was observed for the HDL and LDL (Fig. 1 a) . Most ofthe cholesterol in both lipoproteins appeared as ester (Fig. 2) . Similar injections into anhepatic rats ( Fig. 1 b) produced plasma cholesterol activities which were 10-15% that of intact rats, with virtually all of the tracer found in HDL-free cholesterol (Fig. 2 ).
The clearance ofchylomicron ['4C]cholesterol (79% cholesterol ester) from the plasma of intact rats occurred promptly ( Fig. 3 a) with a gradual return of the tracer mainly in the heparin-manganese supernate or HDL fraction. The peak of this return coincided with a maximum of tracer-free cholesterol (Fig. 4) at -6 h. The anhepatic rat had a very slow clearance of chylomicron cholesterol ester (Fig. 3 b) with much less return of ['4C]cholesterol in HDL and significantly less as free cholesterol (Fig. 4) . The initial decay of LDL (d = 1.006-1.063) [1,2-3H]-cholesterol ester (86±5% ester, n = 5) was quite different between the intact and anhepatic rats (Fig. 5 a) . The prompt decrease in early activity observed in the intact rat was not seen without the liver. The difference in the second exponential of these two functions was not as pronounced. The plasma decay of Al-HDL (d = 1.063-1.21; heparin sepharose unbound) cholesterol ester (89±8% ester, n = 4) was somewhat slower (Fig. 5  b) for the anhepatic than the control, but this difference was not as great as the LDL (d = 1.006-1.063) cholesterol. The decay data were modeled by a two-compartment system (Fig. 6) assuming that the plasma lipoprotein ester equilibrates with an extravascular pool. Although the fractional transfer rate to the extravascular pool (Table I , LE) and the fractional removal rate (LO) were lower for the anhepatic HDL cholesterol ester than control, the differences were not significant. These respective rates for LDL cholesterol ester in the anhepatic rats (Table I) were significantly less than the intact rats, with the fractional transfer to the extravascular pool -10% of the control value.
The anhepatic fractional removal rate (LO) was 25% of the control. This rate may not reflect irreversible removal but rather transfer to a slowly turning over pool not reflected in the plasma decay data evaluated over the 3-h interval.
After hepatic removal with maintenance of splanchnic function a decrease in plasma cholesterol was noted. This could not be attributed to increasing plasma volumes since initial volumes (16+6 ml; n = 5) (determined by 125I bovine serum albumin distribution) and volumes after 6 h ( 19±4 ml; n = 5) were not significantly different. Plasma albumin concentrations and hematocrit were unchanged over the first postoperative day, while a gradual decrease in plasma cholesterol occurred. In the 5 h after hepatectomy, significant decreases in both HDL (d = 1.063-1.21) and LDL (d < 1.063) (Table II) cholesterol were observed. The phospholipid contents of these anhepatic lipoproteins were also significantly less after 5 h. The free and ester cholesterol partitions were similar for respective lipoproteins in the intact and anhepatic states. The apolipoproteins ofboth lipoproteins were less, but this was significant only for LDL.
The mass transfer for the two compartment system (Fig. 6 ) was calculated from (a) the lipoprotein cholesterol ester contents (Table II) of intact and anhepatic rats obtained 5 h after hepatectomy, (b) the kinetic parameters obtained from the radiolabeled data (Table I) determined at 2-5 h after hepatectomy. Although steady-state conditions pertained for the controls, this was not true for anhepatic rats. Estimates ofthe sizes of the extravascular pool and of mass return to plasma from this pool in the anhepatic state are minimum values if the fall in plasma lipoprotein ester is followed by the fall in extravascular ester, and maximum if preceded by the fall in extravascular ester. We have no data to determine which condition exists. The mass estimates for both lipoproteins are, therefore, most useful in comparisons between the two, but are not absolute values of either. The flux of LDL cholesteryl ester (Ag/min) between the vascular and the extravascular compartment decreased to < 10% of that seen in the intact rat. A decrease was also observed for the mass ofthe extravascular compartment to which the LDL cholesterol ester was transferred. It was 5% of the mass of the extravascular compartment in the intact rat. The flux of Al-HDL cholesterol ester to an extravascular compartment was less affected by the hepatectomy than was the flux of LDL cholesterol ester. About one third of the intact The decay of 125I apo E, added to 1 ml of plasma from standard laboratory diet-fed rats and injected into the renal artery, was appreciably more rapid in the intact than the anhepatic rat (Fig. 7 a) 30 (14) 34 (18) ( 2700 1200 9 (9) Figure 6 . The pool size (within circles, gg±SD [within parentheses], n = 5) and fluxes (Mg/min±SD, n = 4, above and below arrows) for control and anhepatic rats after the arterial injection of respective lipoproteins. The described mass (Table II) and tracer (Table I) tissue (data not shown), confirming the known cholesterol synthetic capacity ofperipheral tissue (22) , the contribution ofthis sterol to plasma cholesterol was modest. The anhepatic rat had -10% of the plasma tracer cholesterol observed for the intact rat after tracer mevalonate. Virtually all of the mevalonate incorporated into anhepatic plasma cholesterol was in free cholesterol in contrast to the intact, where it was found mainly in cholesterol ester. The tracer recoveries in HDL free cholesterol were similar for the anhepatic and intact rats, suggesting that peripheral tissue is an important source of the free cholesterol in this lipoprotein. Only a small amount of synthetic cholesterol was isolated in LDL in the absence of the liver despite known exchange (23) of free cholesterol between the lipoproteins.
The appearance of labeled, newly synthesized free cholesterol in HDL from peripheral tissues may not indicate mass transfer to the lipoprotein but simply exchange. HDL free cholesterol readily exchanges with the free cholesterol of tissues (23, 24) . Hepatic free cholesterol exchanges with this HDL pool even more rapidly than does cholesterol from red cells (24) . The same mechanism responsible for this exchange may produce mass redistribution between tissues and plasma, or vice-versa, if part of the exchanging pool is sequestered (i.e., esterification, hydroxylation, etc.). This equilibrating cholesterol pool between tissues and plasma provides a mechanism for tissue cholesterol transfer which is rapid and relatively independent ofthe receptor activity that governs the rate ofplasma particulate lipoprotein transport.
The return of enteral cholesterol to the plasma after chylomicron clearance also occurs in the HDL free cholesterol pool. This return ofenteral cholesterol was coincident with an incre- 1568 Quarfordt et al. Table I for the respective apolipoproteins.
ment in radiolabeled free cholesterol in plasma and occurred at the same time described (25) for the hepatic hydrolysis of chylomicron cholesterol ester and the loss of this sterol from liver. The rate of fall of anhepatic plasma cholesterol is considerably greater than the turnover rate of cholesterol in the laboratory diet-fed rat (27) . This indicates that this effect of hepatectomy is in addition to the major role which the liver plays in cholesterol anabolism and catabolism. The kinetic studies of cholesterol ester indicate that hepatectomy considerably contracts the extravascular pools with which both Al-HDL and LDL cholesterol ester exchanges. This is particularly pronounced for the low density ester, where virtually the entire equilibrating pool was lost after hepatectomy. This equilibrating hepatic pool may function as a reservoir to buffer plasma lipoprotein concentrations. Data from immunolocalization studies ofboth apo B and apo E in the rat liver has documented (28, 29) considerable amounts ofboth in the extracellular (sinusoidal, Disse) space. It was not determined which lipids were associated with these apoproteins, but these data and the results described here suggest this extracellular space may well be the hepatic site of the buffering lipoproteins. It is likely that the impressive changes in the plasma decay of both LDL cholesterol ester and apo E after hepatectomy were due to the removal of the extracellular stores of these apolipoproteins and/ or lipoproteins. The speculation that these extracellular hepatic stores serve as reservoirs to buffer plasma lipoprotein changes was proposed because of the appreciable lipoprotein concentration decreases after hepatectomy and will require in vivo confirmation. The depletion of plasma albumin produces a transfer of extravascular albumin into the plasma to buffer this loss (30) . It is possible that a similar system occurs with lipoproteins and is fed by an extracellular hepatic pool. This pool, in the space of Disse, would also be continuously influenced by enzymes within this space and by the endosomal processing to which such a pool would be exposed. These influences would suggest that considerable lipoprotein interconversion would occur in such a pool. 
